Prograf MDL Class Cert. Not Doomsday, 1st Circ. Hears
The First Circuit should uphold a lower court's class certification ruling in litigation accusing Astellas Pharma US LLC of delaying entry of a generic form of its immunosuppressant Prograf, Public Justice...To view the full article, register now.
Already a subscriber? Click here to view full article